Smart Insulin Pens Market By Type (First Generation, Second Generation), By Indication (Type 1 Diabetes, Type 2 Diabetes), By Usability (Prefilled, Reusable), By End-User (Hospitals & Clinics, Home Care Settings, Ambulatory Surgical Centers), And Region For 2024– 2031

Report ID: 299219|No. of Pages: 202

product image

Smart Insulin Pens Market By Type (First Generation, Second Generation), By Indication (Type 1 Diabetes, Type 2 Diabetes), By Usability (Prefilled, Reusable), By End-User (Hospitals & Clinics, Home Care Settings, Ambulatory Surgical Centers), And Region For 2024– 2031

Report ID: 299219|Published Date: Dec 2024|No. of Pages: 202|Base Year for Estimate: CAGR of ~12% from 2024 to 2031|Format:   Report available in PDF formatReport available in Excel Format

Smart Insulin Pens Market Valuation – 2024-2031

The rising incidence of diabetes worldwide and the growing use of digital health solutions are driving the smart insulin pens market. According to the analyst from Verified Market Research, the smart insulin pens market is estimated to reach a valuation of USD 332.77 Million over the forecast subjugating around USD 134.4 Million valued in 2023.

Technological advancements that improve insulin delivery accuracy and connectivity, as well as rising demand for personalized diabetes management tools that integrate with continuous glucose monitoring systems, are key factors also driving the market expansion. It enables the market to grow at a CAGR of 12% from 2024 to 2031.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=299219

Smart Insulin Pens Market is estimated to grow at a CAGR of 12% & reach USD 332.77 Mn by the end of 2031

Smart Insulin Pens Market: Definition/Overview

Smart insulin pens are innovative, reusable devices developed to help diabetics administer insulin more effectively. These pens connect to smartphone applications, allowing patients to log their insulin dosages, including timing and amount administered, thereby reducing dosing errors and missed injections. Their applications go beyond only delivery; they include dose reminders, bolus calculators that alter doses depending on current blood glucose levels and carbohydrate intake, and data exchange with healthcare providers. This technological integration improves diabetes care by making it easier for patients to monitor their status and follow treatment regimens, as well as increasing overall glycemic control.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=299219

What are the Aspects Influencing the Growth of the Smart Insulin Pens Market?

The growing global diabetes burden is encouraging the use of smart insulin pens. According to the World Health Organization (WHO), the number of diabetics has increased from 108 million in 1980 to 537 million in 2021, a 400 percent rise. The Centers for Disease Control and Prevention (CDC) says that 37.3 million Americans (11.3% of the population) have diabetes, with Type 2 diabetes accounting for 95% of these cases. According to the International Diabetes Federation (IDF), around 1.2 million adolescents (0-19 years old) have Type 1 diabetes, with new cases requiring insulin therapy increasing by 3.7% per year.

The use of smart insulin pens has increased as digital health technologies have become more widely adopted. The FDA estimates a 156% rise in authorized connected diabetes treatment devices between 2020 and 2023. According to the Office of the National Coordinator for Health Information Technology (ONC), 72% of healthcare providers now prescribe linked diabetes management devices to their patients, up 45% from 2020. According to National Institutes of Health (NIH) data, individuals using linked insulin administration devices demonstrate a 35% increase in glycemic control compared to traditional approaches.

Furthermore, increased healthcare spending and greater insurance coverage for diabetes management devices are propelling market expansion. According to the Centers for Medicare and Medicaid Services (CMS), diabetes-related healthcare costs totaled USD 327 Billion by 2022, with medical equipment and supplies accounting for 23%. The American Diabetes Association (ADA) reports that insurance coverage for smart insulin delivery devices grew by 58% from 2020 to 2023. According to the U.S. Department of Health and Human Services, smart insulin pens are now covered by 85% of private insurance plans, a 40% increase from 2020.

What are the Primary Challenges Faced by the Smart Insulin Pens Market?

The high initial costs associated with smart insulin pens provide a substantial obstacle to market growth. These devices’ superior technology and functionality result in higher prices than traditional insulin administration techniques, making them less accessible, particularly to people in low- and middle-income countries. Limited insurance coverage exacerbates the problem, as many insurance plans do not fully compensate for the prices of these breakthrough gadgets, preventing widespread adoption among cost-conscious patients.

Furthermore, smart insulin pens are not compatible with all insulin kinds, which limits their use for some patient populations. Some devices do not support specific insulin formulations or concentrations, thus patients choose older delivery methods with greater compatibility. This constraint decreases the total market potential for smart insulin pens since healthcare experts offer alternatives that better match the needs and preferences of each patient.

Category-Wise Acumens

What Factors Contribute to the Increasing Demand for Second Generation Pens in the Market?

According to VMR analyst, the second generation pen segment is expected to dominate within the smart insulin pens market during the forecast period due to the increased demand for connectivity and real-time monitoring equipment. Second-generation pens include additional features including Bluetooth connectivity and integration with mobile apps, allowing patients to monitor their insulin doses and glucose levels in real-time. This connectivity boosts user engagement and promotes improved diabetes care, making these pens more popular among patients looking for more effective options.

Second-generation smart insulin pens prioritize user experience, with intuitive interfaces and capabilities that facilitate insulin administration. These improvements not only increase usability but also encourage greater adherence to treatment regimens, as users find it easier to successfully control their diabetes with these modern gadgets.

Furthermore, advancements in data analysis capabilities provide a substantial contribution to the segment’s growth. Second-generation pens can assess insulin usage and glucose levels, providing useful information to users and healthcare providers. This data-driven approach promotes tailored treatment programs, allowing patients to make informed decisions about their diabetes management and, ultimately, generating demand for these revolutionary gadgets.

How Does the Increasing Prevalence of Type 2 Diabetes Drive the Demand for Smart Insulin Pens?

The type 2 diabetes segment is estimated to hold the largest share of the smart insulin pens market during the forecast period due to increased obesity rates and sedentary lifestyles. As more people are diagnosed with Type 2 diabetes, there is a greater need for effective management tools, such as smart insulin pens, which enable improved insulin administration and tracking, ultimately improving patient outcomes.

The improved patient satisfaction and adherence linked to smart insulin pens is a further substantial driver. These devices include features like dosage reminders and data tracking to help people manage their insulin intake more effectively. Smart pens’ ease and user-friendly design result in greater compliance rates among Type 2 diabetic patients, consolidating their market share.

Furthermore, the use of technology in diabetes management is a key component driving the Type 2 diabetes segment’s growth. Smart insulin pens connect to mobile apps that offer real-time data analysis and personalized suggestions. This technological development not only facilitates insulin administration but also allows patients to make more educated health decisions, increasing the use of these devices among Type 2 diabetes.

Gain Access to Smart Insulin Pens Market Report Methodology

https://www.verifiedmarketresearch.com/select-licence/?rid=299219

Country/Region-wise Acumens

What are the Drivers Contributing to the Dominance of North America in the Market?

North America is estimated to dominate the smart insulin pens market during the forecast period. North America has a high diabetes burden, particularly in the United States. According to the Centers for Disease Control and Prevention (CDC)’s 2022 National Diabetes Statistics Report, 37.3 million Americans (11.3% of the population) have diabetes, with approximately 28.7 million being diagnosed. Also, the CDC claims that 96 million American adults have prediabetes, representing a significant potential market for diabetes management devices such as smart insulin pens.

Furthermore, the robust healthcare system and attractive reimbursement regulations in North America encourage the use of advanced diabetic treatment devices. According to the American Diabetes Association’s Economic Costs of Diabetes report (2022), the total direct medical costs for diagnosed diabetes in the United States amounted to $237 billion. Medicare pays for around 61% of diabetes-related medical expenses for enrollees, making modern devices such as smart insulin pens more accessible to patients.

What Factors Influence the Market of Smart Insulin Pens in the Asia Pacific Region?

The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The Asia Pacific region is experiencing an extraordinary increase in diabetes cases, particularly in China and India. According to the International Diabetes Federation’s (IDF) Atlas 2023, 206 million adults in the Western Pacific region have diabetes, with China accounting for 140.9 million cases. The IDF expects these numbers to rise by 27% by 2045, generating a sizable market for improved diabetes control products such as smart insulin pens. Also, India recorded 77 million diabetes cases in 2023, according to the Indian Council of Medical Research (ICMR).

Furthermore, governments in the Asia Pacific are significantly increasing healthcare spending and adopting diabetes management initiatives. According to the World Health Organization (WHO), China’s healthcare expenditure increased at an average yearly rate of 12.6% between 2018 and 2023. The Japanese Ministry of Health, Labour, and Welfare has allocated ¥2.3 trillion (about USD 15.6 Billion) for diabetes care and management technology in their 2023 healthcare budget, a 15% increase from the previous year.

Competitive Landscape

The competitive landscape of the smart insulin pens market is characterized by a constant interplay of innovation, technical developments, and strategic collaborations. As the demand for effective diabetes management solutions increases, manufacturers are working on improving product features including Bluetooth connectivity, real-time data tracking, and user-friendly interfaces.

Some of the prominent players operating in the smart insulin pens market include:

Emperra GmbH, Berlin-Chemie, Companion Medical, Inc., Bigfoot Biomedical, Sanofi, Digital Medics Pty Ltd., Pendiq, Jiangsu Deflu Medical Device Co., Novo Nordisk, Medtronic plc, Eli Lilly and Company.

Latest Developments:

Smart Insulin Pens Market KEY DEVELOPMENTS

  • In March 2022, Novo Nordisk released its Smart Insulin Pens and made them available in the UK, enabling people with diabetes who get treatment from the NHS to utilize gadgets for the first time that can track and record dose information. The new NovoPen 6 and NovoPen Echo Plus insulin self-injection pens record data such as the time and quantity that insulin is given. With a near-field communication (NFC) connection, the data is transmitted to an app where patients and medical professionals may review it.

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2020-2031

Growth Rate

CAGR of ~12% from 2024 to 2031

Base Year for Valuation

2023

Historical Period

2018-2022

Forecast Period

2024-2031

Quantitative Units

Value in USD Million

Report Coverage

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

Segments Covered
  • Type
  • Indication
  • Usability
  • End-User
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players
  • Emperra GmbH
  • Berlin-Chemie
  • Companion Medical, Inc.
  • Bigfoot Biomedical
  • Sanofi
  • Digital Medics Pty Ltd.
  • Pendiq
  • Jiangsu Deflu Medical Device Co.
  • Novo Nordisk
  • Medtronic plc
  • Eli Lilly and Company
Customization

Report customization along with purchase available upon request

Smart Insulin Pens Market, by Category

Type:

  • First Generation Pens
  • Second Generation Pens

Indication:

  • Type 1 Diabetes
  • Type 2 Diabetes

Usability:

  • Prefilled
  • Reusable

End-User:

  • Hospitals and Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers

Region:Indication

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

 

Frequently Asked Questions

Smart Insulin Pens Market was valued at USD 134.4 Million in 2023 and is projected to reach USD 332.77 Million by 2031, growing at a CAGR of 12% during the forecasted period 2024 to 2031.

Smart insulin pens are innovative, reusable devices developed to help diabetics administer insulin more effectively. These pens connect to smartphone applications, allowing patients to log their insulin dosages, including timing and amount administered, thereby reducing dosing errors and missed injections.

The major players in the market are Emperra GmbH, Berlin-Chemie, Companion Medical, Inc., Bigfoot Biomedical, Sanofi, Digital Medics Pty Ltd., Pendiq, Jiangsu Deflu Medical Device Co., Novo Nordisk, Medtronic plc, Eli Lilly and Company.

The global Smart Insulin Pens Market is segmented based on Type, Indication, Usability, End-User, and Geography.

The sample report for the Smart Insulin Pens Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

1 INTRODUCTION OF GLOBAL SMART INSULIN PENS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL SMART INSULIN PENS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL SMART INSULIN PENS MARKET, BY TYPE
5.1 Overview
5.2 First Generation Pens
5.3 Second Generation Pens

6 GLOBAL SMART INSULIN PENS MARKET, BY INDICATION
6.1 Overview
6.2 Type 1 Diabetes
6.3 Type 2 Diabetes

7 GLOBAL SMART INSULIN PENS MARKET, BY USABILITY
7.1 Overview
7.2 Prefilled
7.3 Reusable

8 GLOBAL SMART INSULIN PENS MARKET, BY END-USER
8.1 Overview
8.2 Hospitals and Clinics
8.3 Home Care Settings
8.4 Home Care Settings

9 GLOBAL SMART INSULIN PENS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.2 Middle East and Africa

10 GLOBAL SMART INSULIN PENS MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 Emperra GmbH
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Berlin-Chemie
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Companion Medical, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Bigfoot Biomedical
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Sanofi
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Digital Medics Pty Ltd.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Pendiq
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Jiangsu Deflu Medical Device Co.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Novo Nordisk
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.11 Medtronic plc
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

12 KEY DEVELOPMENTS
12.1 Product Launches/Developments
12.2 Mergers and Acquisitions
12.3 Business Expansions
12.4 Partnerships and Collaborations

13 Appendix
13.1 Related Research

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Smart Insulin Pens Market

report-detail

Download Sample Report

View More Reports